Legal & General Group PLC Verona Pharma PLC Transaction History

Legal & General Group PLC

  • $431 Billion
  • Q3 2025

A detailed history of Legal & General Group PLC transactions in Verona Pharma PLC stock. As of the latest transaction made, Legal & General Group PLC holds 81,654 shares of VRNA stock, worth $8.73 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
81,654
Previous 80,280 1.71%
Holding current value
$8.73 Million
Previous $7.59 Million 14.73%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025
BUY
$90.08 - $106.69 $123,769 - $146,592
1,374 Added 1.71%
81,654 $8.71 Million
Q2 2025

Aug 12, 2025
SELL
$53.9 - $98.68 $3.31 Million - $6.07 Million
-61,465 Reduced 43.36%
80,280 $7.59 Million
Q1 2025

May 15, 2025
SELL
$44.81 - $69.63 $65,915 - $102,425
-1,471 Reduced 1.03%
141,745 $9 Million
Q4 2024

Feb 13, 2025
SELL
$28.71 - $47.02 $6.74 Million - $11 Million
-234,788 Reduced 62.11%
143,216 $6.65 Million
Q3 2024

Feb 28, 2025
BUY
$15.46 - $30.16 $3.63 Million - $7.08 Million
234,788 Added 163.94%
378,004 $10.9 Million
Q3 2024

Nov 14, 2024
SELL
$15.46 - $30.16 $95,913 - $187,112
-6,204 Reduced 1.61%
378,004 $10.9 Million
Q2 2024

May 29, 2025
BUY
$11.48 - $17.02 $3.5 Million - $5.18 Million
304,635 Added 382.84%
384,208 $5.56 Million
Q2 2024

Aug 14, 2024
BUY
$11.48 - $17.02 $3.5 Million - $5.18 Million
304,635 Added 382.84%
384,208 $5.56 Million
Q1 2024

May 29, 2025
SELL
$15.3 - $20.24 $951,231 - $1.26 Million
-62,172 Reduced 43.86%
79,573 $1.28 Million
Q1 2024

May 14, 2024
SELL
$15.3 - $20.24 $14,397 - $19,045
-941 Reduced 1.17%
79,573 $1.28 Million
Q4 2023

May 29, 2025
SELL
$11.94 - $20.47 $731,098 - $1.25 Million
-61,231 Reduced 43.2%
80,514 $1.6 Million
Q4 2023

Feb 15, 2024
BUY
$11.94 - $20.47 $151,208 - $259,232
12,664 Added 18.66%
80,514 $1.6 Million
Q3 2023

Nov 14, 2023
BUY
$16.3 - $22.09 $111,655 - $151,316
6,850 Added 11.23%
67,850 $1.11 Million
Q2 2023

Aug 14, 2023
BUY
$19.41 - $23.43 $710,871 - $858,100
36,624 Added 150.25%
61,000 $1.29 Million
Q1 2023

May 15, 2023
SELL
$18.06 - $25.27 $5,002 - $6,999
-277 Reduced 1.12%
24,376 $489,000
Q4 2022

Feb 14, 2023
BUY
$9.84 - $26.13 $242,585 - $644,182
24,653 New
24,653 $644,000

Others Institutions Holding VRNA

# of Institutions
274
Shares Held
77.1M
Call Options Held
686K
Put Options Held
442K
View Full List

About Verona Pharma plc

VRNA Quotes by TradingView
  • Ticker VRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,954,200
  • Market Cap $6.52B
  • Description
  • Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...
More about VRNA
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email